article thumbnail

RNA editing: emerging from CRISPR’s shadow

BioPharma Drive: Drug Pricing

Early study data from Wave Life Sciences suggests how editing RNA may yield viable medicines. Large and small drugmakers say such results are just the start.

RNA 141
article thumbnail

RNA that doesn't age

Science Daily: Pharmacology News

Certain RNA molecules in the nerve cells in the brain last a life time without being renewed. RNAs are generally short-lived molecules that are constantly reconstructed to adjust to environmental conditions. Neuroscientists have now demonstrated that this.

RNA 140
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Research shows how RNA 'junk' controls our genes

Science Daily: Pharmacology News

The new study focuses on critical snippets of RNA in the tiny, transparent roundworm Caenorhabditis elegans (C. The study provides a detailed map of the 3'UTR regions of RNA in C. 3'UTRs (untranslated regions) are segments of RNA involved in gene regulation.

RNA 122
article thumbnail

Researchers develop RNA-targeting technology for precisely manipulating parts of human genes

Science Daily: Pharmacology News

Researchers have harnessed a bacterial immune defense system, known as CRISPR, to efficiently and precisely control the process of RNA splicing.

RNA 117
article thumbnail

New imaging method enables detailed RNA analysis of the whole brain

Science Daily: Pharmacology News

Researchers have developed a groundbreaking microscopy method that enables detailed three-dimensional (3D) RNA analysis at cellular resolution in whole intact mouse brains. The new method, called TRISCO, has the potential to transform our understanding of brain function, both in normal conditions and in disease, according to the new study.

RNA 107
article thumbnail

RNA processing in health and disease: challenges and opportunities of the field

Drug Target Review

In this article Drug Target Review’s Izzy Wood spoke to Sam Hasson, Director of Target Biology at Rgenta Therapeutics, a biotech firm in Massachusetts, US, that aims to develop small molecule therapeutics to target RNA processing. The field is faced with a number of obstacles that require specifically assay technologies to surmount.

RNA 96
article thumbnail

Engineers design more powerful RNA vaccines

Science Daily: Pharmacology News

By adding synergistic self-adjuvanting properties to Covid-19 RNA vaccines, researchers showed they could significantly boost the immune response generated in mice.

RNA 94